Dogwood Therapeutics, Inc.
- DWTX
- NASDAQ
- Biotechnology
- Antiviral Drug Development
- Immunology (Viral Triggers)
$1.25
Today +2.46%Quote Oct 19, 2026, 04:54 PM UTC
−29.07%over the last month
Max drawdown −29.1%From 1-month high −29.1%3 months −11.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Dogwood Therapeutics
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
8
Market value
$42.5M
Quote Oct 19
Floor
$1.19
5.1% below price
Resistance
$1.29
3.5% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about DWTXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free